Genvisc 850 (injection) Pregnancy Warnings
It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.
Safety has not been established.
US FDA pregnancy category: Not assigned.
Risk Summary: Animal studies have failed to reveal evidence of fertility impairment or teratogenicity.
See references
